Allscripts Healthcare Solutions, Inc. (MDRX) Shares Bought by Dimensional Fund Advisors LP
Dimensional Fund Advisors LP lifted its position in shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) by 26.9% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 9,171,285 shares of the software maker’s stock after purchasing an additional 1,943,496 shares during the period. Dimensional Fund Advisors LP owned about 5.05% of Allscripts Healthcare Solutions worth $117,026,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Thrivent Financial For Lutherans boosted its position in shares of Allscripts Healthcare Solutions by 255.4% in the 1st quarter. Thrivent Financial For Lutherans now owns 111,780 shares of the software maker’s stock valued at $1,418,000 after purchasing an additional 80,330 shares during the period. Wesbanco Bank Inc. increased its position in Allscripts Healthcare Solutions by 131.4% during the second quarter. Wesbanco Bank Inc. now owns 147,587 shares of the software maker’s stock worth $1,883,000 after buying an additional 83,807 shares during the period. Dalton Greiner Hartman Maher & Co. acquired a new position in Allscripts Healthcare Solutions during the second quarter worth approximately $1,276,000. OppenheimerFunds Inc. increased its position in Allscripts Healthcare Solutions by 9.4% during the first quarter. OppenheimerFunds Inc. now owns 31,445 shares of the software maker’s stock worth $399,000 after buying an additional 2,701 shares during the period. Finally, Victory Capital Management Inc. increased its position in Allscripts Healthcare Solutions by 6.8% during the second quarter. Victory Capital Management Inc. now owns 1,627,164 shares of the software maker’s stock worth $20,763,000 after buying an additional 103,395 shares during the period.
TRADEMARK VIOLATION WARNING: This piece was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright laws. The legal version of this piece can be accessed at https://www.thecerbatgem.com/2017/10/02/allscripts-healthcare-solutions-inc-mdrx-shares-bought-by-dimensional-fund-advisors-lp.html.
Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) opened at 14.23 on Monday. The stock’s market capitalization is $2.57 billion. Allscripts Healthcare Solutions, Inc. has a 12 month low of $9.80 and a 12 month high of $14.45. The company has a 50 day moving average price of $13.01 and a 200 day moving average price of $12.40.
Allscripts Healthcare Solutions (NASDAQ:MDRX) last released its quarterly earnings data on Thursday, August 3rd. The software maker reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.15 by ($0.04). The business had revenue of $426.10 million during the quarter, compared to analyst estimates of $424.94 million. Allscripts Healthcare Solutions had a negative net margin of 11.54% and a positive return on equity of 5.97%. The firm’s revenue for the quarter was up 10.2% on a year-over-year basis. During the same period in the previous year, the firm posted $0.14 EPS. Equities research analysts predict that Allscripts Healthcare Solutions, Inc. will post $0.62 earnings per share for the current year.
A number of equities research analysts have weighed in on the company. Citigroup Inc. boosted their price objective on Allscripts Healthcare Solutions from $13.00 to $14.00 and gave the company a “neutral” rating in a research note on Monday, August 7th. Zacks Investment Research raised shares of Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research report on Wednesday, August 9th. Cantor Fitzgerald raised shares of Allscripts Healthcare Solutions from a “neutral” rating to an “overweight” rating and set a $12.00 price objective on the stock in a research report on Tuesday, August 15th. Maxim Group restated a “buy” rating and issued a $16.00 price objective on shares of Allscripts Healthcare Solutions in a research note on Friday, August 4th. Finally, Royal Bank Of Canada initiated coverage on shares of Allscripts Healthcare Solutions in a research note on Tuesday, September 19th. They issued an “outperform” rating and a $17.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and twelve have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $15.24.
In related news, EVP Brian Farley sold 5,000 shares of the stock in a transaction dated Thursday, September 14th. The shares were sold at an average price of $13.52, for a total value of $67,600.00. Following the completion of the transaction, the executive vice president now owns 196,607 shares of the company’s stock, valued at $2,658,126.64. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, President Richard J. Poulton sold 15,000 shares of the stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $13.56, for a total transaction of $203,400.00. The disclosure for this sale can be found here. Insiders sold 35,000 shares of company stock worth $473,800 over the last quarter. 0.75% of the stock is currently owned by corporate insiders.
About Allscripts Healthcare Solutions
Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.
Receive News & Stock Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related stocks with our FREE daily email newsletter.